Latigo Biotherapeutics, Inc. LTGO
13.52 USD +0.19 (+1.43%)
At closeNov 11, 2026, 4:00 PM EST
13.52 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
13.36 Day range 14.35
10.24 52-week range 25.93
- YTD
- -25.92%
- 1 year
- -25.92%
News
defenseworld.net Latigo Biotherapeutics, Inc. (NASDAQ:LTGO) Stock Has Consensus Price Target of $52.25 According to Analysts Latigo Biotherapeutics, Inc. (NASDAQ: LTGO - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the five research firms that are presently covering the firm,…
benzinga.com Latigo Biotherapeutics Q3 EPS $(0.55) Beats $(0.58) Estimate Latigo Biotherapeutics (NASDAQ:LTGO) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.58) by 5.17 percent. This is a 98.14 percent increase over losses…
globenewswire.com Latigo Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights Phase 3 bunionectomy and open-label safety trials of onzotrigine remain on track for initiation with topline results expected in the second half of 2027
globenewswire.com Latigo Biotherapeutics Announces CEO Transition to Support the Company's Next Phase of Growth Todd N. Smith, a seasoned executive with deep experience commercializing pain therapies, appointed as president and chief executive officer to lead Latigo through planned late-stage development and…